PPT-Dr. Gilles Salles Novel and Emerging Strategies for Diffuse Large B-Cell Lymphoma

Dr Gilles SALLES Chief of the Lymphoma Service Memorial Sloan Kettering Cancer Center New York New agents in DLBCL Recently FDA approved agents Polatuzumab vedotin Selinexor. Lymphoma is divided into two major categories Hodgkin lymphoma HL and nonHodgkin lymphoma NHL Mantle cell lymphoma MCL is one of about 70 di64256erent subtypes of NHL Lymphoma may arise in any one of three types of lymphocytes B lymphocytes B cells . Wade Coriell. Anisha Sud. King & Spalding LLP, Houston. 22. nd. International Petroleum Environmental Consortium Conference. Denver, November 17-19, 2015. Society’s Autonomous Right to a Clean Environment . IRIA- 1192. Case Discussion. A 46 year old male with complaints of. . -. Dysphagia. x 2 weeks. . -. Epigastric. Pain x 2 weeks. . -Vomiting x 40 hours. An upper gastrointestinal endoscopy was done which revealed a gastro-duodenal junction growth invading the . : un . cauchemar. N’avez-vous jamais ?. Erré dans les couloirs à la recherche de votre salle ?. Eu des problèmes . Pour réserver une salle ?. Connaître une disponibilité, la capacité de la salle, son équipement ?. Therapeutic Targets in CLL. Venetoclax in Patients With 17p Deletion. Venetoclax in Patients With 17p Deletion (cont). Bendamustine Plus Obinutuzumab. Ibrutinib Plus Ublituximab. Updates in Lymphoma From Recent Congresses. Program Goals. DLBCL Subtypes . 2008 WHO Classification. Other DLBCL Variants. Dissecting DLBCL into Molecularly and Clinically Distinct Subgroups by Gene Expression Profiling. Outcomes Based on DLBCL Subtype Using Gene Expression Profiling. Zahra Mozaheb MD. Assistant professor of Hematology-Oncology . Mashhad University of Medical Science. Iran Mashhad. “5th world Hematologists congress" . Lymphoid malignancies are remarkable and. . Non-Hodgkin’s lymphoma (. NHL) is a term covering all . lymphoproliferative. system malignancies except Hodgkin's lymphoma . The disease is rare in subject under 30 years of age and incidence increase with age . Around two-thirds of all cases are diagnosed in people over 60 years . . 1 AN UPDATE OF PATHOGENETIC FEATURES WCRJ 2016; 3 (2): e715 INTRODUCTION Extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue represents approximately 8% of all non-Hodgkin Helpline: 800 500 9976 | helpline@lymphoma.org Understanding LymphomaDiffuse Large B-Cell Lymphoma: Relapsed/Refractory Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin l Souto GR, Pereira TSF, Castro AF, Mesquita RA. Diffuse large B-cell eMail: jced@jced.es Scopus DOI® System oi:10.4317/jced.51127http://dx.doi.org/10.4317/jced.51127IntroductionDiffuse large B-cell Overview Case 3 • 59 year old man with lymphadenopathy in the neck, supraclavicular area, inguinal area . He states that he has had LN for at least 18 months and they have waxed and waned . . leukaemia. CLL-related conditions. Monoclonal B-cell . lymphocytosis. (MBL. ). Small lymphocytic lymphoma (SLL. ). Richter’s syndrome (RS). Richter’s syndrome (RS) represents the development of an. Dr.Rahim. . Zahedi. Rapid enlargement of thyroid. . Acute infectious thyroiditis . ( onset of pain, firmness, tenderness, redness or swelling in the anterior aspect of the neck, sudden fever, dysphagia and .